Serum integrative omics reveals the landscape of human diabetic kidney disease

• Main Authors: Shijia Liu (Author), Yuan Gui (Author), Mark S. Wang (Author), Lu Zhang (Author), Tingting Xu (Author), Yuchen Pan (Author), Ke Zhang (Author), Ying Yu (Author), Liangxiang Xiao (Author), Yi Qiao (Author), Christopher Bonin (Author), Geneva Hargis (Author), Tao Huan (Author), Yanbao Yu (Author), Jianling Tao (Author), Rong Zhang (Author), Donald L. Kreutzer (Author), Yanjiao Zhou (Author), Xiao-Jun Tian (Author), Yanlin Wang (Author), Haiyan Fu (Author), Xiaofei An (Author), Silvia Liu (Author), Dong Zhou (Author)
• Format: Book
• Published: Elsevier, 2021-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objective: Diabetic kidney disease (DKD) is the most common microvascular complication of type 2 diabetes mellitus (2-DM). Currently, urine and kidney biopsy specimens are the major clinical resources for DKD diagnosis. Our study proposes to evaluate the diagnostic value of blood in monitoring the o...